arbre (1) modèle (1) matériau (1) analyse (1) santé (1) décision (1) coût (1) âge (1) Mexique (1) Costs (1) Cost effectiveness (1) Complications (1) Methods (1) Weights and measures (1) Values (1) Respiratory syncytial virus (1) Perspective (1) Patients (1) Life expectancy (1) Immunoglobulins (1) Health (1) Gestational age (1) Example (1) Cost effectiveness (1) Cost (1) Age (1) Palivizumab (1) Methods (1) Utilization (1) Age (1)